Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BCD-245 by Biocad for Neuroblastoma: Likelihood of Approval
BCD-245 is under clinical development by Biocad and currently in Phase I for Neuroblastoma. According to GlobalData, Phase I drugs...
BCD-245 by Biocad for Osteosarcoma: Likelihood of Approval
BCD-245 is under clinical development by Biocad and currently in Phase I for Osteosarcoma. According to GlobalData, Phase I drugs...
BCD-245 by Biocad for Ewing Sarcoma: Likelihood of Approval
BCD-245 is under clinical development by Biocad and currently in Phase I for Ewing Sarcoma. According to GlobalData, Phase I...